Transcription elongation factor S-II is required for definitive hematopoiesis
Transcription elongation factor S-II is required for definitive hematopoiesis
复制标题
DOI:
10.1128/mcb.26.8.3194-3203.2006
复制
发表时间:
2006-04-01
影响因子:
5.3
通讯作者:
Sekimizu, K
中科院分区:
文献类型:
--
作者:
Ito, T;Arimitsu, N;Sekimizu, K
Transcription elongation factor S-II/TFIIS promotes readthrough of transcriptional blocks by stimulating nascent RNA cleavage activity of RNA polymerase 11 in vitro. The biologic significance of S-H function in higher eukaryotes, however, remains unclear. To determine its role in mammalian development, we generated S-II-deficient mice through targeted gene disruption. Homozygous null mutants died at midgestation with marked pallor, suggesting severe anemia. S-II-/- embryos had a decreased number of definitive erythrocytes in the peripheral blood and disturbed erythroblast differentiation in fetal liver. There was a dramatic increase in apoptotic cells in S-II-/- fetal liver, which was consistent with a reduction in Bcl-x(L), gene expression. The presence of phenotypically defined hematopoietic stem cells and in vitro colony-forming hematopoietic progenitors in S-II-/- fetal liver indicates that S-II is dispensable for the generation and differentiation of hematopoietic stem cells. S-II-deficient fetal liver cells, however, exhibited a loss of long-term repopulating potential when transplanted into lethally irradiated adult mice, indicating that S-II deficiency causes an intrinsic defect in the self-renewal of hematopoietic stem cells. Thus, S-II has critical and nonredundant roles in definitive hematopoiesis.